Manipal Health Enterprises IPO listing tomorrow: Here’s what GMP indicates ahead of market debut

Investors are set to see the market debut of Manipal Health Enterprises IPO on August 5, with shares scheduled to list on the BSE and NSE mainboard platforms. However, muted investor sentiment and weak grey market trends suggest the stock may witness a subdued opening.

The IPO is currently trading at a discount of around Rs 5-6 in the grey market, pointing towards an estimated listing price of nearly Rs 584 per share, compared with the upper end of the IPO price band of Rs 590. While the grey market premium (GMP) is often tracked as an indicator of market mood, it remains an unofficial and unregulated market signal and does not guarantee listing-day performance.

The public issue was open for subscription from July 29 to July 31 and received a total subscription of 4.92 times. Demand was primarily driven by institutional investors, with the Qualified Institutional Buyers (QIB) category subscribed 8.25 times.


The Non-Institutional Investor (NII) segment saw moderate interest with a subscription of 1.02 times, while the Retail Individual Investor (RII) portion received bids for 93 per cent of the shares reserved for retail participants.

The Manipal Health Enterprises IPO consisted of a fresh issue of 13.56 crore equity shares worth Rs 8,000 crore and an Offer for Sale (OFS) of 2.16 crore shares valued at Rs 1,275.22 crore. The overall issue size stood at Rs 9,275.22 crore.

The company fixed the IPO price band at Rs 560 to Rs 590 per share.

Kotak Mahindra Capital served as the book-running lead manager for the issue, while KFin Technologies acted as the registrar.

Manipal Health Enterprises IPO GMP Today

Ahead of the listing, shares of Manipal Health Enterprises are trading at a grey market discount of approximately Rs 5-6. This suggests a possible listing around Rs 584 per share, slightly below the IPO’s upper price band.

Market participants often monitor GMP to gauge investor appetite before listing, but since grey market transactions are not officially regulated, investors should consider broader factors such as company fundamentals, valuation, sector outlook and market conditions before making investment decisions.

About Manipal Health Enterprises

Founded in 2010, Manipal Health Enterprises has emerged as one of India’s leading healthcare providers, with a wide network of multi-specialty hospitals, clinics and diagnostic centres.

The company provides advanced tertiary and quaternary healthcare services across key specialties, including oncology, cardiology, neurology, orthopaedics, organ transplantation and preventive healthcare.

As of March 31, 2026, Manipal Health Enterprises operated 49 hospitals with 13,037 licensed beds and 21 clinics across India. The organisation has a workforce of more than 24,000 employees, including over 11,000 nurses and 6,300 paramedics.

Over the years, the healthcare chain has expanded through acquisitions, investments in medical infrastructure and increased adoption of digital healthcare solutions.

How Manipal Health Enterprises Plans to Use IPO Funds

The company plans to allocate a significant portion of the fresh issue proceeds towards strengthening its financial position.

Around Rs 5,378 crore from the IPO proceeds will be used for debt repayment, helping reduce borrowing costs and improve the balance sheet. Another Rs 574 crore is planned for acquiring a minority stake in its step-down subsidiary, Sahyadri Hospitals.

The remaining funds will be utilised for general corporate purposes and supporting future expansion plans.

With a strong healthcare footprint and a large-scale IPO, Manipal Health Enterprises’ listing will be closely watched by investors to assess market confidence in India’s growing hospital sector.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)